e(ye)BRAIN GMBH
This article was originally published in Start Up
Executive Summary
Could the eyes hold the key to diagnosing neurologic conditions by associating eye movement behavior to specific areas of the brain? French start-up e(ye)BRAIN certainly thinks so, and as a result has developed a brain tracking medical device that its inventor claims is able to diagnose Parkinson's disease and multiple sclerosis.
You may also be interested in...
Start-Up Previews (01/2011)
A preview of the emerging health companies profiled in the current issue of Start-Up. This month's profile group, "Benlysta May Lead Wave Of New Approvals For Lupus Drugs," features profiles of Azano Pharmaceuticals, Resolve Therapeutics and SuppreMol. Plus these Start-Ups Across Health Care: biocrea, e(ye)BRAIN, MiCardia and Omthera Pharmaceuticals
US FDA Complete Response Letter Rates Vary With Sponsor Size
Pink Sheet infographic illustrates benefits of big pharma’s resources and experience.